341 related articles for article (PubMed ID: 22052278)
1. Treatment of peristomal pyoderma gangrenosum with topical crushed dapsone.
Handler MZ; Hamilton H; Aires D
J Drugs Dermatol; 2011 Sep; 10(9):1059-61. PubMed ID: 22052278
[TBL] [Abstract][Full Text] [Related]
2. [Peristomal pyoderma gangrenosum in a patient with ulcero-hemorrhagic rectocolitis].
Giroux JM; Ouellet A; Heppell J; Lacroix M
Ann Dermatol Venereol; 1987; 114(8):935-9. PubMed ID: 3426072
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Systemic Dapsone Treatment for Pyoderma Gangrenosum: A Retrospective Review.
Din RS; Tsiaras WG; Li DG; Mostaghimi A
J Drugs Dermatol; 2018 Oct; 17(10):1058-1060. PubMed ID: 30365585
[TBL] [Abstract][Full Text] [Related]
4. Management of peristomal pyoderma gangrenosum.
Kiran RP; O'Brien-Ermlich B; Achkar JP; Fazio VW; Delaney CP
Dis Colon Rectum; 2005 Jul; 48(7):1397-403. PubMed ID: 15868233
[TBL] [Abstract][Full Text] [Related]
5. Early diagnosis and early corticosteroid administration improves healing of peristomal pyoderma gangrenosum in inflammatory bowel disease.
Funayama Y; Kumagai E; Takahashi K; Fukushima K; Sasaki I
Dis Colon Rectum; 2009 Feb; 52(2):311-4. PubMed ID: 19279428
[TBL] [Abstract][Full Text] [Related]
6. Complete and durable clinical response of malignant pyoderma to tacrolimus in combination with dapsone and prednisone.
Ciurea AM; Guitart J; Brieva J
Arch Dermatol; 2010 Jan; 146(1):102-3. PubMed ID: 20083712
[No Abstract] [Full Text] [Related]
7. Topical tacrolimus (FK506) in the treatment of recalcitrant parastomal pyoderma gangrenosum associated with Crohn's disease: report of two cases.
Khurrum Baig M; Marquez H; Nogueras JJ; Weiss EG; Wexner SD
Colorectal Dis; 2004 Jul; 6(4):250-3. PubMed ID: 15206967
[TBL] [Abstract][Full Text] [Related]
8. Pyoderma gangrenosum in a patient with bullous systemic lupus erythematosus.
Sakamoto T; Hashimoto T; Furukawa F
Eur J Dermatol; 2002; 12(5):485-7. PubMed ID: 12370142
[TBL] [Abstract][Full Text] [Related]
9. [Pyoderma gangrenosum: report of 11 cases].
López de Maturana D; Amaro P; Aranibar L; Segovia L
Rev Med Chil; 2001 Sep; 129(9):1044-50. PubMed ID: 11725468
[TBL] [Abstract][Full Text] [Related]
10. Beclometasone inhaler used to treat pyoderma gangrenosum.
Chriba M; Skellett AM; Levell NJ
Clin Exp Dermatol; 2010 Apr; 35(3):337-8. PubMed ID: 20500206
[TBL] [Abstract][Full Text] [Related]
11. Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report.
Kouklakis G; Moschos J; Leontiadis GI; Kadis S; Mpoumponaris A; Molyvas E; Minopoulos GI
Rom J Gastroenterol; 2005 Dec; 14(4):401-3. PubMed ID: 16400359
[TBL] [Abstract][Full Text] [Related]
12. Sclerokeratitis and facial skin lesions: a case report of pyoderma gangrenosum and its response to dapsone therapy.
Teasley LA; Foster CS; Baltatzis S
Cornea; 2007 Feb; 26(2):215-9. PubMed ID: 17251816
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the Efficacy of Topical Dapsone Treatment for Pyoderma Gangrenosum: A Retrospective Case Series.
Li DG; Din RS; Tsiaras WG; Mostaghimi A
J Cutan Med Surg; 2018; 22(6):650-651. PubMed ID: 30322308
[No Abstract] [Full Text] [Related]
14. Peristomal pyoderma gangrenosum and inflammatory bowel disease.
Cairns BA; Herbst CA; Sartor BR; Briggaman RA; Koruda MJ
Arch Surg; 1994 Jul; 129(7):769-72. PubMed ID: 7912923
[TBL] [Abstract][Full Text] [Related]
15. Use of infliximab in pyoderma gangrenosum.
Hewitt D; Tait C
Australas J Dermatol; 2007 May; 48(2):95-8. PubMed ID: 17535196
[TBL] [Abstract][Full Text] [Related]
16. Pyoderma gangrenosum following isotretinoin therapy for acne nodulocystic.
Tinoco MP; Tamler C; Maciel G; Soares D; Avelleira JC; Azulay D
Int J Dermatol; 2008 Sep; 47(9):953-6. PubMed ID: 18937662
[TBL] [Abstract][Full Text] [Related]
17. Pyoderma gangrenosum.
Ghosh SK; Bandyopadhyay D; Chatterjee G
J Assoc Physicians India; 2008 Sep; 56():712. PubMed ID: 19086358
[No Abstract] [Full Text] [Related]
18. The use of etanercept in the treatment of peristomal pyoderma gangrenosum.
Kim FS; Pandya AG
Clin Exp Dermatol; 2012 Jun; 37(4):442-3. PubMed ID: 22582915
[No Abstract] [Full Text] [Related]
19. Successful treatment of pyoderma gangrenosum with topical 0.5% nicotine cream.
Patel GK; Rhodes JR; Evans B; Holt PJ
J Dermatolog Treat; 2004 Apr; 15(2):122-5. PubMed ID: 15204166
[TBL] [Abstract][Full Text] [Related]
20. Ustekinumab for peristomal pyoderma gangrenosum.
Fahmy M; Ramamoorthy S; Hata T; Sandborn WJ
Am J Gastroenterol; 2012 May; 107(5):794-5. PubMed ID: 22552250
[No Abstract] [Full Text] [Related]
[Next] [New Search]
